GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
GLP-1 & Obesity Medicine

Treatments in Development

What's in development, who's developing it, and what phase it's reached. Looking for a recruiting study instead? Find My Trial →

About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Filters
Clear all

392 compounds

Not yet reported Recruiting trials available

AAV9-GLB1

National Human Genome Research Institute (NHGRI) Route not yet reported
Not yet reported Recruiting trials available

Abaloparatide

University of Wisconsin, Madison Route not yet reported
Not yet reported Recruiting trials available

ABBV-295

AbbVie Route not yet reported
Not yet reported Recruiting trials available

ABP-671

Atom Therapeutics Co., Ltd Route not yet reported
Not yet reported Recruiting trials available

AC2993

AstraZeneca Route not yet reported
Phase 2 Recruiting trials available

Aleniglipron

GSBR-1290

Structure Therapeutics mono GLP-1 Oral
Not yet reported Recruiting trials available

Alpha-Lipoic Acid

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Route not yet reported
Not yet reported Recruiting trials available

Antihyperglycemic therapy

Takeda Route not yet reported
Not yet reported Recruiting trials available

AP-306

Alebund Pharmaceuticals Route not yet reported
Not yet reported Recruiting trials available

Apraglutide

VectivBio AG Route not yet reported
Not yet reported Recruiting trials available

AT2221

Amicus Therapeutics Route not yet reported
Not yet reported Recruiting trials available

ATB200

Amicus Therapeutics Route not yet reported
Not yet reported Recruiting trials available

ATL-001

Atlas Molecular Pharma Route not yet reported
Not yet reported Recruiting trials available

atumelnant

Crinetics Pharmaceuticals Inc. Route not yet reported
Not yet reported Recruiting trials available

AZD0780

AstraZeneca Route not yet reported
Not yet reported Recruiting trials available

AZD6234

AstraZeneca Route not yet reported
Not yet reported Recruiting trials available

BBI-001

Bond Biosciences Route not yet reported
Not yet reported Recruiting trials available

Beinaglutide

Second Xiangya Hospital of Central South University Route not yet reported
Not yet reported Recruiting trials available

Best medical management

Beijing Tiantan Hospital Route not yet reported
Not yet reported Recruiting trials available

BGE-102

BGE-102

BioAge Labs, Inc. Oral
Not yet reported Recruiting trials available

BGM0504

BrightGene Bio-Medical Technology Co., Ltd. Route not yet reported
Not yet reported Recruiting trials available

BI 10773

Boehringer Ingelheim Route not yet reported
Not yet reported Recruiting trials available

BI 3034701

BI 3034701

Boehringer Ingelheim Route not yet reported
Not yet reported Recruiting trials available

BI 456906

Boehringer Ingelheim Route not yet reported
Not yet reported Recruiting trials available

Blood samples

Rigshospitalet, Denmark Route not yet reported
Not yet reported Recruiting trials available

Brenipatide

Eli Lilly and Company Route not yet reported
Not yet reported Recruiting trials available

Bydureon BCise

Vivani Medical, Inc Route not yet reported
Under FDA review Recruiting trials available

CagriSema

Novo Nordisk dual GLP-1/amylin Injectable
Not yet reported Recruiting trials available

Compare change is SVC and SMA flow due to GIP antagonist GIP(3-30)NH2

Vanderbilt University Medical Center Route not yet reported
Not yet reported Recruiting trials available

Continue GLP/GIP

The Cleveland Clinic Route not yet reported
Not yet reported Recruiting trials available

CX11

Vincentage Pharma Co., Ltd Route not yet reported
Not yet reported Recruiting trials available

DA-1726

NeuroBo Pharmaceuticals Inc. Route not yet reported
Not yet reported Recruiting trials available

Diane-35

Xiaojun Chen Route not yet reported
Not yet reported Recruiting trials available

Dose escalation to 2 mg semaglutide weekly then no semaglutide

The University of Texas Health Science Center, Houston Route not yet reported
Not yet reported Recruiting trials available

dulaglutide

Eli Lilly and Company Route not yet reported
Not yet reported Recruiting trials available

ECC4703

Eccogene Route not yet reported
Not yet reported Recruiting trials available

ECC5004

Eccogene Route not yet reported
Not yet reported Recruiting trials available

Ecnoglutide

Hangzhou Sciwind Biosciences Co., Ltd. Route not yet reported
Phase 2 Recruiting trials available

Eloralintide

LY3841136

Eli Lilly mono amylin Injectable
Not yet reported Recruiting trials available

Enlicitide

Merck Sharp & Dohme LLC Route not yet reported
Not yet reported Recruiting trials available

Evolocumab

Amgen Route not yet reported
Not yet reported Recruiting trials available

Exenatide

Joslin Diabetes Center Route not yet reported
Not yet reported Recruiting trials available

Exendin-

The University of Texas Health Science Center at San Antonio Route not yet reported
Not yet reported Recruiting trials available

Exendin-9,39

Mayo Clinic Route not yet reported
Not yet reported Recruiting trials available

FGF23-related hypophosphataemic rickets and osteomalacia

Kyowa Kirin Korea Co., Ltd. Route not yet reported
Not yet reported Recruiting trials available

Fingolimod Hydrochloride

General Hospital of Shenyang Military Region Route not yet reported
Not yet reported Recruiting trials available

G-Pen

Xeris Pharmaceuticals Route not yet reported
Not yet reported Recruiting trials available

GIP-A

University Hospital, Gentofte, Copenhagen Route not yet reported
Not yet reported Recruiting trials available

GIP[3-30]NH2

Frederikke Koefoed-Hansen Route not yet reported
Not yet reported Recruiting trials available

glepaglutide

Zealand Pharma Route not yet reported
Not yet reported Recruiting trials available

GLP-1 (7-36) amide

Johns Hopkins University Route not yet reported
Not yet reported Recruiting trials available

GLP-1 medication

The Cleveland Clinic Route not yet reported
Not yet reported Recruiting trials available

GLP-1 RAs

Shanghai 10th People's Hospital Route not yet reported
Not yet reported Recruiting trials available

GLP-1 Stop for 1 week

Fu Jen Catholic University Hospital Route not yet reported
Not yet reported Recruiting trials available

GLP-1/FGF21 dual agonist

Shanghai Zhongshan Hospital Route not yet reported
Not yet reported Recruiting trials available

GLP-1A

Stanford University Route not yet reported
Not yet reported Recruiting trials available

GLP-1RA

Kaiser Permanente Route not yet reported
Not yet reported Recruiting trials available

GlucaGen

Zealand Pharma Route not yet reported
Not yet reported Recruiting trials available

Glucagon Infusion

The University of Texas Health Science Center at San Antonio Route not yet reported
Not yet reported Recruiting trials available

Glucagon-like peptide-1 receptor agonist：Semaglutide

The First Affiliated Hospital with Nanjing Medical University Route not yet reported
Not yet reported Recruiting trials available

Glucagon, 0-0.5 ng/kg/min

Columbia University Route not yet reported
Not yet reported Recruiting trials available

Glucose

Rutgers, The State University of New Jersey Route not yet reported
Not yet reported Recruiting trials available

glucose dependent insulinotropic polypeptide

Hvidovre University Hospital Route not yet reported
Not yet reported Recruiting trials available

Glycerol

Rutgers, The State University of New Jersey Route not yet reported
Not yet reported Recruiting trials available

GnRH antagonist

Xiaojun Chen Route not yet reported
Not yet reported Recruiting trials available

GnRHa

Xiaojun Chen Route not yet reported
Not yet reported Recruiting trials available

Gold

Xiaojun Chen Route not yet reported
Not yet reported Recruiting trials available

Growth Hormone, Human

Columbia University Route not yet reported
Not yet reported Recruiting trials available

GUB-UCN2

Gubra A/S Route not yet reported
Not yet reported Recruiting trials available

guideline-based treatment for DM

General Hospital of Shenyang Military Region Route not yet reported
Not yet reported Recruiting trials available

GZR18

Gan & Lee Pharmaceuticals. Route not yet reported
Not yet reported Recruiting trials available

GZR33 Injection

Gan & Lee Pharmaceuticals. Route not yet reported
Not yet reported Recruiting trials available

HDM1002 100 mg

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Route not yet reported
Not yet reported Recruiting trials available

HDM1005 1

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Route not yet reported
Not yet reported Recruiting trials available

HDM1005 2

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Route not yet reported
Not yet reported Recruiting trials available

HDM1702

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Route not yet reported
Not yet reported Recruiting trials available

HM11260C

Hanmi Pharmaceutical Company Limited Route not yet reported
Not yet reported Recruiting trials available

HM15275

Hanmi Pharmaceutical Company Limited Route not yet reported
Not yet reported Recruiting trials available

HPN-100

Amgen Route not yet reported
Not yet reported Recruiting trials available

HRS-1301 Tablet

Shandong Suncadia Medicine Co., Ltd. Route not yet reported
Not yet reported Recruiting trials available

HRS9531 Tablet

Fujian Shengdi Pharmaceutical Co., Ltd. Route not yet reported
Not yet reported Recruiting trials available

Hyperinsulinemic, euglycemic clamp

Vanderbilt University Route not yet reported
Not yet reported Recruiting trials available

IN026 Injection

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Route not yet reported
Not yet reported Recruiting trials available

Incretins

University of Campania Luigi Vanvitelli Route not yet reported
Not yet reported Recruiting trials available

Injected GLP-1 Receptor Agonists and Dual Agonists

University of Colorado, Denver Route not yet reported
Not yet reported Recruiting trials available

Insulin Aspart

Novo Nordisk A/S Route not yet reported
Not yet reported Recruiting trials available

Insulin glargine

Medical University of Vienna Route not yet reported
Not yet reported Recruiting trials available

Intravenous saline

University Hospital Tuebingen Route not yet reported
Not yet reported Recruiting trials available

ITCA 650

Intarcia Therapeutics Route not yet reported
Not yet reported Recruiting trials available

JS002

Shanghai Junshi Bioscience Co., Ltd. Route not yet reported
Not yet reported Recruiting trials available

KBP-336

KeyBioscience AG Route not yet reported
Not yet reported Recruiting trials available

Lactate

Rutgers, The State University of New Jersey Route not yet reported
Not yet reported Recruiting trials available

LAF 237

The University of Texas Health Science Center at San Antonio Route not yet reported
Not yet reported Recruiting trials available

Laroprovstat

AstraZeneca Route not yet reported
Not yet reported Recruiting trials available

Laroprovstat/Rosuvastatin 1

AstraZeneca Route not yet reported
Not yet reported Recruiting trials available

Laroprovstat/Rosuvastatin 2

AstraZeneca Route not yet reported
Not yet reported Recruiting trials available

LCI699

Novartis Route not yet reported
Not yet reported Recruiting trials available

LCZ 696

Mayo Clinic Route not yet reported
Not yet reported Recruiting trials available

Letrozole

Xiaojun Chen Route not yet reported
Not yet reported Recruiting trials available

Liraglutide

Cedars-Sinai Medical Center Route not yet reported
Not yet reported Recruiting trials available

Liraglutide / Semaglutide

Dasman Diabetes Institute Route not yet reported
Not yet reported Recruiting trials available

Lixisenatide

Sanofi Route not yet reported
Not yet reported Recruiting trials available

Locally available low-dose semaglutide

Asian Institute Of Medical Sciences Route not yet reported
Not yet reported Recruiting trials available

LY2189265

Eli Lilly and Company Route not yet reported
Not yet reported Recruiting trials available

LY2606368

Dana-Farber Cancer Institute Route not yet reported
Not yet reported Recruiting trials available

LY3457263

Eli Lilly and Company Route not yet reported
Not yet reported Recruiting trials available

LY3532226

Eli Lilly and Company Route not yet reported
Not yet reported Recruiting trials available

Macupatide

Eli Lilly and Company Route not yet reported
Not yet reported Recruiting trials available

Maridebart Cafraglutide

Amgen Route not yet reported
Not yet reported Recruiting trials available

Mazdutide

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Route not yet reported
Not yet reported Recruiting trials available

MDR-001

MindRank AI Ltd Route not yet reported
Not yet reported Recruiting trials available

MET097

Pfizer Route not yet reported
Not yet reported Recruiting trials available

MET233 and MET097

Pfizer Route not yet reported
Not yet reported Recruiting trials available

Metformin

Ziauddin University Route not yet reported
Not yet reported Recruiting trials available

Methylprednisolone

National Human Genome Research Institute (NHGRI) Route not yet reported
Not yet reported Recruiting trials available

Micro-glucagon

Insel Gruppe AG, University Hospital Bern Route not yet reported
Not yet reported Recruiting trials available

Mirabegron

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Route not yet reported
Not yet reported Recruiting trials available

MK-0616

Merck Sharp & Dohme LLC Route not yet reported
Not yet reported Recruiting trials available

MNCs

Post Graduate Institute of Medical Education and Research, Chandigarh Route not yet reported
Not yet reported Recruiting trials available

NLY01

Johns Hopkins University Route not yet reported
Not yet reported Recruiting trials available

NNC0487-0111

Novo Nordisk A/S Route not yet reported
Not yet reported Recruiting trials available

NNC0519-0130

Novo Nordisk A/S Route not yet reported
Not yet reported Recruiting trials available

Non-GLP-1 RA based glucose lowering drugs

AstraZeneca Route not yet reported
Not yet reported Recruiting trials available

Obesity medication with liraglutide or semaglutide

Karolinska Institutet Route not yet reported
Not yet reported Recruiting trials available

Octreotide

St. James's Hospital, Ireland Route not yet reported
Not yet reported Recruiting trials available

Oral GLP-1

University Hospital, Basel, Switzerland Route not yet reported
Approved Recruiting trials available

Orforglipron

LY3502970

Eli Lilly mono GLP-1 Oral
Not yet reported Recruiting trials available

Other drugs

The Affiliated Hospital of Hangzhou Normal University Route not yet reported
Not yet reported Recruiting trials available

Pancreatic Polypeptide

University Hospital, Gentofte, Copenhagen Route not yet reported
Not yet reported Recruiting trials available

Pasireotide

University of Colorado, Denver Route not yet reported
Not yet reported Recruiting trials available

Petrelintide

Zealand Pharma Route not yet reported
Not yet reported Recruiting trials available

PF-08653944

Pfizer Route not yet reported
Not yet reported Recruiting trials available

PF-08653945

Pfizer Route not yet reported
Not yet reported Recruiting trials available

PG-102

ProGen. Co., Ltd. Route not yet reported
Not yet reported Recruiting trials available

Pitavastatin Calcium

Eccogene Route not yet reported
Not yet reported Recruiting trials available

PJ009

Chongqing Peg-Bio Biopharm Co., Ltd. Route not yet reported
Not yet reported Recruiting trials available

PM577a

Prime Medicine, Inc. Route not yet reported
Not yet reported Recruiting trials available

PPI deprescribing

Duke University Route not yet reported
Not yet reported Recruiting trials available

Pramlintide

Cheryl Rosenfeld, DO Route not yet reported
Not yet reported Recruiting trials available

Prednisone

National Human Genome Research Institute (NHGRI) Route not yet reported
Not yet reported Recruiting trials available

r-glucagon

Sanofi Route not yet reported
Not yet reported Recruiting trials available

Rapid ESC-guideline based secondary prevention following myocardial infaction

Zuyderland Medisch Centrum Route not yet reported
Not yet reported Recruiting trials available

RAY1225

Guangdong Raynovent Biotech Co., Ltd Route not yet reported
Not yet reported Recruiting trials available

RBD5044

RBD5044

Ribocure Pharmaceuticals AB Route not yet reported
Not yet reported Recruiting trials available

Receptor Agonists

Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders Route not yet reported
Not yet reported Recruiting trials available

Recombinant human hyaluronidase PH20

Halozyme Therapeutics Route not yet reported
Not yet reported Recruiting trials available

REMD-477

University of California, San Diego Route not yet reported
Phase 3 Recruiting trials available

Retatrutide

LY3437943

Eli Lilly triple GLP-1/GIP/glucagon Injectable
Not yet reported Recruiting trials available

RGB-5088

Hangzhou Reprogenix Bioscience, Inc Route not yet reported
Phase 3 Recruiting trials available

Ribupatide

KAI-9531 / HRS9531

Kailera Therapeutics dual GLP-1/GIP Oral & injectable
Not yet reported Recruiting trials available

Rituximab

National Human Genome Research Institute (NHGRI) Route not yet reported
Not yet reported Recruiting trials available

RN3161

Ikaria Bioscience Pty Ltd Route not yet reported
Not yet reported Recruiting trials available

Rosuvastatin 1

AstraZeneca Route not yet reported
Not yet reported Recruiting trials available

Rosuvastatin 2

AstraZeneca Route not yet reported
Approved Recruiting trials available

Semaglutide

Novo Nordisk mono GLP-1 Oral & injectable
Not yet reported Recruiting trials available

semaglutide or tirzepatide

Mayo Clinic Route not yet reported
Not yet reported Recruiting trials available

SGLT2i

Ana Palanca Route not yet reported
Not yet reported Recruiting trials available

SGLT2i or GLP-1RA

Kaiser Permanente Route not yet reported
Not yet reported Recruiting trials available

SHR-1918

SHR-1918

Beijing Suncadia Pharmaceuticals Co., Ltd Route not yet reported
Not yet reported Recruiting trials available

SHR3824

Jiangsu HengRui Medicine Co., Ltd. Route not yet reported
Not yet reported Recruiting trials available

Sirolimus

National Human Genome Research Institute (NHGRI) Route not yet reported
Not yet reported Recruiting trials available

Sitagliptin

Kafrelsheikh University Route not yet reported
Not yet reported Recruiting trials available

Sloe

Fondazione Policlinico Universitario Agostino Gemelli IRCCS Route not yet reported
Not yet reported Recruiting trials available

stem cell transplantation

Post Graduate Institute of Medical Education and Research, Chandigarh Route not yet reported
Not yet reported Recruiting trials available

Sulfasalazine

Eccogene Route not yet reported
Not yet reported Recruiting trials available

TCC1727 tablet 120mg

Beijing Tide Pharmaceutical Co., Ltd Route not yet reported
Not yet reported Recruiting trials available

Teduglutide

University Health Network, Toronto Route not yet reported
Not yet reported Recruiting trials available

Teriparatide

Columbia University Route not yet reported
Not yet reported Recruiting trials available

THRV-1268

Thryv Therapeutics, Inc. Route not yet reported
Approved Recruiting trials available

Tirzepatide

LY3298176

Eli Lilly dual GLP-1/GIP Injectable
Not yet reported Recruiting trials available

TQF3250 capsules

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Route not yet reported
Not yet reported Recruiting trials available

Transplant of stem cells with CD3+/CD19+ depletion

Children's Hospital of Philadelphia Route not yet reported
Not yet reported Recruiting trials available

UBT251

The United Bio-Technology (Hengqin) Co., Ltd. Route not yet reported
Not yet reported Recruiting trials available

VCT220

Vincentage Pharma Co., Ltd Route not yet reported
Not yet reported Recruiting trials available

VHB937

Novartis Pharmaceuticals Route not yet reported
Not yet reported Recruiting trials available

Vildagliptin 50 MG

Sadat City University Route not yet reported
Not yet reported Recruiting trials available

XTL6001

Shanghai Xitaili Biomedicine Technology co., Ltd. Route not yet reported
Not yet reported Recruiting trials available

XW003 injection

Hangzhou Sciwind Biosciences Co., Ltd. Route not yet reported
Not yet reported Recruiting trials available

zovaglutide Arm 1

Beijing QL Biopharmaceutical Co.,Ltd Route not yet reported
Not yet reported

[14C]HRS9531

Fujian Shengdi Pharmaceutical Co., Ltd. Route not yet reported
Not yet reported

[68Ga] Ga-DO3A-VS-Cys40-Exendin-4

Sanofi Route not yet reported
Not yet reported

[68Ga] Ga-DO3A-VS-Cys40-Tuna-2

Sanofi Route not yet reported
Not yet reported

[Part 1.1] IDG-16177

IlDong Pharmaceutical Co Ltd Route not yet reported
Not yet reported

[Part 2] IDG-16177

IlDong Pharmaceutical Co Ltd Route not yet reported
Not yet reported

[Part1.2] IDG-16177

IlDong Pharmaceutical Co Ltd Route not yet reported
Not yet reported

1.5 mg or 2.0 mg CJC-1134-PC

ConjuChem Route not yet reported
Not yet reported

14C Tirzepatide

Eli Lilly and Company Route not yet reported
Not yet reported

2 OGTTs with and without GLP-1 analogue

Vanderbilt-Ingram Cancer Center Route not yet reported
Not yet reported

200 mg FHND1002（fasting）

Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. Route not yet reported
Not yet reported

200mg FHND1002

Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. Route not yet reported
Not yet reported

AAE581

Novartis Pharmaceuticals Route not yet reported
Not yet reported

AC-201

TWi Biotechnology, Inc. Route not yet reported
Not yet reported

AC2307

AstraZeneca Route not yet reported
Not yet reported

Active: WST-057 4mL (146 mg pirenzepine free base monohydrate) topical solution

WinSanTor, Inc Route not yet reported
Not yet reported

Adjustment of insulin doses CFT

University Tunis El Manar Route not yet reported
Not yet reported

Adjustment of insulin doses DAR

University Tunis El Manar Route not yet reported
Not yet reported

Albiglutide

GlaxoSmithKline Route not yet reported
Not yet reported

alirocumab SAR236553

Sanofi Route not yet reported
Not yet reported

ALXN1840

Alexion Pharmaceuticals, Inc. Route not yet reported
Phase 3

Amycretin

Novo Nordisk dual GLP-1/amylin Oral & injectable
Not yet reported

AP-101

AL-S Pharma Route not yet reported
Not yet reported

AP026 (TQA2226) for injection

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. Route not yet reported
Not yet reported

ASP1941

Astellas Pharma Inc Route not yet reported
Not yet reported

AZD0186

AstraZeneca Route not yet reported
Not yet reported

AZD1656

AstraZeneca Route not yet reported
Not yet reported

BM2216 Extended-Release Tablets

Zhejiang Anglikang Pharmaceutical Co., Ltd. Route not yet reported
Not yet reported

BMS-823778

Bristol-Myers Squibb Route not yet reported
Not yet reported

BMS-852927

Bristol-Myers Squibb Route not yet reported
Not yet reported

bremelanotide

Palatin Technologies, Inc Route not yet reported
Not yet reported

BXT-51072

Synvista Therapeutics, Inc Route not yet reported
Not yet reported

BYM338 10 mg/kg

Novartis Pharmaceuticals Route not yet reported
Not yet reported

BZA 20 mg/CE 0.45 mg

Pfizer Route not yet reported
Not yet reported

CCX140-B

Amgen Route not yet reported
Not yet reported

CD34 Stem Cell Selection Therapy

Diane George Route not yet reported
Not yet reported

CDX 6114

Société des Produits Nestlé (SPN) Route not yet reported
Not yet reported

CE-326,597 100 mg QD

Pfizer Route not yet reported
Not yet reported

CER-001

Cerenis Therapeutics, SA Route not yet reported
Not yet reported

CIL001

Cilcare SAS Route not yet reported
Not yet reported

CJC-1134-PC

ConjuChem Route not yet reported
Not yet reported

CKD-386

Chong Kun Dang Pharmaceutical Route not yet reported
Not yet reported

CKD-501

Chong Kun Dang Pharmaceutical Route not yet reported
Not yet reported

CKD-501, D745, D150

Chong Kun Dang Pharmaceutical Route not yet reported
Not yet reported

CKD-519 100mg

Chong Kun Dang Pharmaceutical Route not yet reported
Not yet reported

Closed loop with sensor, Insulin and Liraglutide

Albert Einstein College of Medicine Route not yet reported
Not yet reported

Cohort A: ORMD-0801

Oramed, Ltd. Route not yet reported
Not yet reported

Cotadutide

AstraZeneca Route not yet reported
Not yet reported

CTP-499

Concert Pharmaceuticals Route not yet reported
Not yet reported

Danuglipron

Pfizer Route not yet reported
Not yet reported

Dasiglucagon

Novo Nordisk A/S Route not yet reported
Not yet reported

DD01

Neuraly, Inc. Route not yet reported
Not yet reported

DISC-1459

Disc Medicine, Inc Route not yet reported
Not yet reported

DLBS1033

Dexa Medica Group Route not yet reported
Not yet reported

Efpeglenatide

Sanofi Route not yet reported
Not yet reported

elamipretide (MTP-131) 1% topical ophthalmic solution

Stealth BioTherapeutics Inc. Route not yet reported
Not yet reported

EPI-743 200 mg

PTC Therapeutics Route not yet reported
Not yet reported

ETC-1002

Esperion Therapeutics, Inc. Route not yet reported
Not yet reported

ethinyl estradiol and levonorgestrel; exenatide

AstraZeneca Route not yet reported
Not yet reported

Exenatide (50ng/min for 30 minutes loading followed by 25ng/min maintenance) and glucagon 12.5ng/kg/min

Cambridge University Hospitals NHS Foundation Trust Route not yet reported
Not yet reported

Exenatide (GLP-1RA) or Liraglutide

Kaiser Permanente Route not yet reported
Not yet reported

Exenatide, Liraglutide

University of Dundee Route not yet reported
Not yet reported

Experimental: GLP1-RA (exenatide) administration

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau Route not yet reported
Not yet reported

Fixed-dose combination of gemigliptin/dapagliflozin/metformin 50/10/

LG Chem Route not yet reported
Not yet reported

G-Pump™

Xeris Pharmaceuticals Route not yet reported
Not yet reported

GIP + alanine

University Hospital, Gentofte, Copenhagen Route not yet reported
Not yet reported

GIP Bolus

Diabeteszentrum Bad Lauterberg im Harz Route not yet reported
Not yet reported

GIP Clamp

Diabeteszentrum Bad Lauterberg im Harz Route not yet reported
Not yet reported

GIP/GLP-1a

Dr Adnan Agha Route not yet reported
Not yet reported

GLP-1 High Dose

Indiana University Route not yet reported
Not yet reported

GLP-1 Low Dose

Indiana University Route not yet reported
Not yet reported

GLP-1 Mid-Range Dose

Indiana University Route not yet reported
Not yet reported

GLP-1 Receptor Agonists + Behavioral modification

Nova Scotia Health Authority Route not yet reported
Not yet reported

GLP-1-9,36 infusion

Adrian Vella Route not yet reported
Not yet reported

Glucagon 12.5ng/kg/min

Cambridge University Hospitals NHS Foundation Trust Route not yet reported
Not yet reported

Glucagon 12.5ng/kg/min and 0.9% saline

Cambridge University Hospitals NHS Foundation Trust Route not yet reported
Not yet reported

Glucagon for Injection

Fresenius Kabi USA, LLC Route not yet reported
Not yet reported

Glucagon hydrochloride

Charite University, Berlin, Germany Route not yet reported
Not yet reported

Glucagon IM

Eli Lilly and Company Route not yet reported
Not yet reported

Glucagon Nasal Powder

Eli Lilly and Company Route not yet reported
Not yet reported

Glucagon Nasal Powder [Baqsimi]

Eli Lilly and Company Route not yet reported
Not yet reported

Glucagon RTU

Xeris Pharmaceuticals Route not yet reported
Not yet reported

Glucagon-Like Peptide- 1 (GLP-1) infusion

University of Maryland, Baltimore Route not yet reported
Not yet reported

Glucagon-Like-Peptide-1/Regadenoson/Perflutren Lipid Microsphere

Mayo Clinic Route not yet reported
Not yet reported

GS1168

GS1168

Gritgen Therapeutics Co., Ltd. Injectable
Not yet reported

GSK189075

GlaxoSmithKline Route not yet reported
Not yet reported

GSK2315698

GlaxoSmithKline Route not yet reported
Not yet reported

GSK2398852

GlaxoSmithKline Route not yet reported
Not yet reported

GW869682

GlaxoSmithKline Route not yet reported
Not yet reported

GZ402665

Genzyme, a Sanofi Company Route not yet reported
Not yet reported

GZR102

Gan & Lee Pharmaceuticals. Route not yet reported
Not yet reported

HDG1901

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Route not yet reported
Not yet reported

HE3286

Harbor Therapeutics Route not yet reported
Not yet reported

HR17031

Jiangsu HengRui Medicine Co., Ltd. Route not yet reported
Not yet reported

HR20031 FDC

Shandong Suncadia Medicine Co., Ltd. Route not yet reported
Not yet reported

HS-10582

Jiangsu Hansoh Pharmaceutical Co., Ltd. Route not yet reported
Not yet reported

HSG4112

Glaceum Route not yet reported
Not yet reported

Human GLP-1 (7-36) amide

Jeppe Skov Route not yet reported
Not yet reported

I.v. NNC 0113-0987

Novo Nordisk A/S Route not yet reported
Not yet reported

IM Glucagon

Eli Lilly and Company Route not yet reported
Not yet reported

Increasing doses of GLP-1

University Hospital, Basel, Switzerland Route not yet reported
Not yet reported

INGAP-Peptide

Exsulin Corporation Route not yet reported
Not yet reported

insulin degludec/liraglutide

Novo Nordisk A/S Route not yet reported
Not yet reported

Insulin glargine HOE901

Sanofi Route not yet reported
Not yet reported

INSULIN GLARGINE/LIXISENATIDE HOE901/AVE0010

Sanofi Route not yet reported
Not yet reported

Insulin Lispro SAR342434

Sanofi Route not yet reported
Not yet reported

Insulin monotherapy with premixed insulin NPH 30/70

Sanofi Route not yet reported
Not yet reported

Intranasal glucagon

University Health Network, Toronto Route not yet reported
Not yet reported

Intravenous glucagon

University Hospital Tuebingen Route not yet reported
Not yet reported

ITCA 650 Osmotic Mini Pump 20/60 mcg/day

Intarcia Therapeutics Route not yet reported
Not yet reported

ITCA 650 Osmotic Mini Pump 60 mcg/day

Intarcia Therapeutics Route not yet reported
Not yet reported

JNJ-64565111

Janssen Research & Development, LLC Route not yet reported
Not yet reported

JNJ-64565111 Dose Level 1

Janssen Research & Development, LLC Route not yet reported
Not yet reported

JNJ-64565111 Dose Level 2

Janssen Research & Development, LLC Route not yet reported
Not yet reported

JNJ-64565111 Dose Level 3

Janssen Research & Development, LLC Route not yet reported
Not yet reported

JTT-130

Akros Pharma Inc. Route not yet reported
Not yet reported

KAI-7535

Kailera Route not yet reported
Not yet reported

KQ-791

Kaneq Bioscience Limited Route not yet reported
Not yet reported

Lanthanum Carbonate (Fosrenol, BAY77-1931) - chewable tablet

Bayer Route not yet reported
Not yet reported

Leptin plus Pramlintide

Oregon Health and Science University Route not yet reported
Not yet reported

Lilly Glucagon

Xeris Pharmaceuticals Route not yet reported
Not yet reported

LIPO-102

Neothetics, Inc Route not yet reported
Not yet reported

Liraglutide for 26 weeks

Jens Faber Route not yet reported
Not yet reported

Liraglutide injection,RD12014

Sunshine Lake Pharma Co., Ltd. Route not yet reported
Not yet reported

Liraglutide Pen Injector [Saxenda]

General Committee of Teaching Hospitals and Institutes, Egypt Route not yet reported
Not yet reported

LY2393910

Eli Lilly and Company Route not yet reported
Not yet reported

LY2403021

University Hospital, Gentofte, Copenhagen Route not yet reported
Not yet reported

LY2409021

Eli Lilly and Company Route not yet reported
Not yet reported

LY2922083

Eli Lilly and Company Route not yet reported
Not yet reported

LY2963016

Eli Lilly and Company Route not yet reported
Not yet reported

LY900014

Eli Lilly and Company Route not yet reported
Not yet reported

MBL949

Novartis Pharmaceuticals Route not yet reported
Not yet reported

MEDI0382

MedImmune LLC Route not yet reported
Not yet reported

MEDI0382 Formulation 2

MedImmune LLC Route not yet reported
Not yet reported

MEDI0382 Formulation 3

MedImmune LLC Route not yet reported
Not yet reported

metformin and liraglutide

University Medical Centre Ljubljana Route not yet reported
Not yet reported

Metformin XR plus liraglutide

Woman's Route not yet reported
Not yet reported

Metformin-GLP-1 Receptor Agonist

Xinqiao Hospital of Chongqing Route not yet reported
Not yet reported

Mini-glucagon

Insel Gruppe AG, University Hospital Bern Route not yet reported
Not yet reported

Miscellany

Ana Palanca Route not yet reported
Not yet reported

MK0557

Merck Sharp & Dohme LLC Route not yet reported
Not yet reported

MK0653, ezetimibe

Organon and Co Route not yet reported
Not yet reported

MK0653, ezetimibe / Duration of Treatment: 6 Weeks

Organon and Co Route not yet reported
Not yet reported

MKC253 Inhalation Powder

Mannkind Corporation Route not yet reported
Not yet reported

morphine and glucagon

National Taiwan University Hospital Route not yet reported
Not yet reported

MSDC-0602K

Cirius Therapeutics, Inc. Route not yet reported
Not yet reported

MT-1186

Shionogi Route not yet reported
Not yet reported

Nasal Glucagon

Eli Lilly and Company Route not yet reported
Not yet reported

native glp-1

University of Aarhus Route not yet reported
Not yet reported

Native human Glucagon-like Peptide-1 ( GLP-1(7-36))

University Hospital, Gentofte, Copenhagen Route not yet reported
Not yet reported

NEX-22A, a prolonged release formulation of liraglutide

Nanexa AB Route not yet reported
Not yet reported

NGM282

NGM Biopharmaceuticals, Inc Route not yet reported
Not yet reported

NGM313

NGM Biopharmaceuticals, Inc Route not yet reported
Not yet reported

NM-002

9 Meters Biopharma, Inc. Route not yet reported
Not yet reported

NNC 0123-0000-0338

Novo Nordisk A/S Route not yet reported
Not yet reported

NNC0174-0833

Novo Nordisk A/S Route not yet reported
Not yet reported

NNC0363-0845

Novo Nordisk A/S Route not yet reported
Not yet reported

NNC0471-0119 H

NNC0471-0119 H

Novo Nordisk A/S Route not yet reported
Not yet reported

NNC9204-1513

Novo Nordisk A/S Route not yet reported
Not yet reported

NPO-11

Nihon Pharmaceutical Co., Ltd Route not yet reported
Not yet reported

Omarigliptin

Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders Route not yet reported
Not yet reported

Oral antidiabetic drugs: Metformin, Sulfonylureas (2nd generation), Thiazolidinediones, α-Glucosidase inhibitors, and Gl

Third Military Medical University Route not yet reported
Not yet reported

oral NNC 0113-0987

Novo Nordisk A/S Route not yet reported
Not yet reported

Other DPP4-i

Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders Route not yet reported
Not yet reported

PB-119

PegBio Co., Ltd. Route not yet reported
Not yet reported

Period 1 Visit 1 - Cold PET-CT Vehicle, Visit 2 -Warm PET-CT Glucagon

Imperial College London Route not yet reported
Not yet reported

Period 2 - Visit 1 Warm Control vehicle, Visit 2 Warm Glucagon, Visit 3 Cold control

Imperial College London Route not yet reported
Not yet reported

Period 2 - Visit 1 Warm control, visit 2 cold control, visit 3 warm glucagon

Imperial College London Route not yet reported
Not yet reported

Period 2 - Visit 1 Warm Glucagon, Visit 2 Cold control , Visit 3 Warm control

Imperial College London Route not yet reported
Not yet reported

Period 2 -Visit 1 cold control, Visit 2 warm control, Visit 3 Warm glucagon

Imperial College London Route not yet reported
Not yet reported

Period 2 -Visit 1 cold control, visit 2 warm glucagon, visit 3 warm control

Imperial College London Route not yet reported
Not yet reported

Period 2- Visit 1 Warm glucagon, visit 2 warm control, visit 3 cold control

Imperial College London Route not yet reported
Not yet reported

PF-04603629

Pfizer Route not yet reported
Not yet reported

PF-04950615

Pfizer Route not yet reported
Not yet reported

PF-06291874

Pfizer Route not yet reported
Not yet reported

PF-06743649

Pfizer Route not yet reported
Not yet reported

PF-07081532

Pfizer Route not yet reported
Not yet reported

Pioglitazone plus exenatide

Dr. Muhammad Abdulghani Route not yet reported
Not yet reported

Pramlintide and glucagon

Baylor College of Medicine Route not yet reported
Not yet reported

Premixed Lyumjev

St. Olavs Hospital Route not yet reported
Not yet reported

Prohibitin-TP01

M.D. Anderson Cancer Center Route not yet reported
Not yet reported

rExenatide-4

CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Route not yet reported
Not yet reported

RN316

Pfizer Route not yet reported
Not yet reported

RNS60

Mario Negri Institute for Pharmacological Research Route not yet reported
Not yet reported

RO4998452

Hoffmann-La Roche Route not yet reported
Not yet reported

ROSE-010 150 mcg

Rose Pharma Inc Route not yet reported
Not yet reported

Routine Lipid Management

Amgen Route not yet reported
Not yet reported

SAP-001

Shanton Pharma Co., Ltd. Route not yet reported
Not yet reported

SAR425899

Sanofi Route not yet reported
Not yet reported

SAR438544

Sanofi Route not yet reported
Not yet reported

SB-509

Sangamo Therapeutics Route not yet reported
Not yet reported

SB-751689

GlaxoSmithKline Route not yet reported
Not yet reported

SLS-005

Merit E. Cudkowicz, MD Route not yet reported
Not yet reported

SP2086

Jiangsu HengRui Medicine Co., Ltd. Route not yet reported
Not yet reported

SYH2069 Injection

CSPC Ouyi Pharmaceutical Co., Ltd. Route not yet reported
Not yet reported

TAK-875

Takeda Route not yet reported
Not yet reported

Tazbentetol

Spinogenix Route not yet reported
Not yet reported

THR-149 dose level 1

ThromboGenics Route not yet reported
Not yet reported

THR-149 dose level 2

ThromboGenics Route not yet reported
Not yet reported

THR-149 dose level 3

ThromboGenics Route not yet reported
Not yet reported

TK006

Jiangsu T-Mab Biopharma Co.,Ltd Route not yet reported
Not yet reported

UBX1325

Unity Biotechnology, Inc. Route not yet reported
Not yet reported

Ultra-rapid insulin

Stanford University Route not yet reported
Not yet reported

very low dose (VLD) glucagon

DiObex Route not yet reported
Phase 3

VK2735

VK2735

Viking Therapeutics dual GLP-1/GIP Oral & injectable
Not yet reported

VX-264

VX-264

Vertex Pharmaceuticals Incorporated Route not yet reported
Not yet reported

Weight loss SOC Treatment with second generation anti-diabetic medications

University of Texas Southwestern Medical Center Route not yet reported
Not yet reported

Xeris Xerisol glucagon

Massachusetts General Hospital Route not yet reported
Not yet reported

Xultophy®

Novo Nordisk A/S Route not yet reported
Not yet reported

YD02-2022

Shanghai Jiao Tong University School of Medicine Route not yet reported
Not yet reported

YM087

Cumberland Pharmaceuticals Route not yet reported
Not yet reported

YP05002

Yaopharma Co., Ltd. Route not yet reported
Not yet reported

ZP4207

Zealand Pharma Route not yet reported
Not yet reported

ZP4207(dasiglucagon) glucagon analogue

Zealand Pharma Route not yet reported